Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PSMC4 encodes Rpt4, one of six distinct AAA+ ATPase subunits (Rpt1–Rpt6) forming the heterohexameric motor in the 19S regulatory particle (RP, PA700) of the 26S proteasome. The 26S proteasome comprises a 20S core particle (CP) that houses proteolytic active sites and a 19S RP that recognizes polyubiquitylated substrates, removes ubiquitin (via Rpn11), unfolds substrates, opens the 20S α-ring gate, and translocates polypeptides into the CP. The AAA+ motor’s subunits, including Rpt4/PSMC4, bind and hydrolyze ATP in a coordinated, staircase-like cycle to power substrate unfolding/translocation; their C‑terminal tails engage α-ring pockets (HbYX-mediated interactions) to open the gate and couple mechanical work to proteolysis. Structural studies in yeast and human proteasomes have resolved distinct conformational states (e.g., s1–s4) and nucleotide occupancy patterns among Rpt subunits, highlighting specialized features such as ADP-bound Rpt6 and variable pore-loop positions that orchestrate substrate processing. As an essential component of the UPS, PSMC4 participates in regulating cell cycle, transcription, DNA replication, signaling, and stress responses; dysfunction or inhibition of the proteasome impacts cancer biology, neurodegeneration, infection, and immunity.
Proteasome inhibitors: reversible or irreversible inhibition of the 20S proteolytic active sites (chymotrypsin-like, etc.), leading to accumulation of ubiquitylated proteins and secondary inhibition of the 19S AAA+ ATPase-driven processing cycle that includes PSMC4. Experimental tool compounds and mechanistic insights indicate that ATP hydrolysis by the heterohexameric AAA+ ring (Rpt1–Rpt6 including Rpt4/PSMC4) drives substrate unfolding/translocation; modulation of nucleotide states alters conformational cycling and gate opening.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 26S proteasome regulatory subunit ATPase 4 (human gene PSMC4; yeast ortholog Rpt4) (PSMC4 (Rpt4)).